GlassScriptPhysician profile
Mordechai Twena
NPI 1114982618
$1,796.32
in general payments reported to CMS, 2019-2025
10 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $920 · 2020: $128 · 2021: $153 · 2022: $396 · 2023: $59.39 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $793.17 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $369.28 | 2019 | |
| Ethicon US, LLC | $231.98 | 2021-2023 | Stratafix |
| Tactile Systems Technology INC | $139.39 | 2025 | Nimbl, Flexitouch Plus |
| Intuitive Surgical, INC. | $83.40 | 2019 | |
| Acell, INC. | $64.04 | 2019 | |
| Integra Lifesciences Corporation | $49.00 | 2021-2023 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Baxter Healthcare | $23.26 | 2020 | |
| Glaxosmithkline, LLC. | $21.81 | 2021 | |
| Becton, Dickinson and Company | $20.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mordechai Twena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.